SecurityENV / Envestnet, Inc. (29404K106)
IndustryBusiness Services, Not Elsewhere Classified
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value69,939,000 shares (as of 2017-12-31)
Total Insiders18
Total Directors11
Total Officers9

Stock Insider Trading (from SEC Form 4)

Envestnet, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

ENV / Envestnet, Inc. insiders include O'Brien Shelly, Smith Gregory A, Thomas Brandon, CROWELL GAYLE A, Crager William, D'Arrigo Peter, Bergman Judson, Arora Anil, Egan Cynthia, Sisteron Yves, Johnson James, Aguilar Luis A Mayer Joshua, Grinis Scott D, Majoros Matthew, FOX JAMES L, and Roame Charles, CHAPIN ROSS K, .

Insider Roster

Insider Dir Off 10% Shares Owned
Arora Anil Envestnet | Yodlee *, Director
X X 101,794
O'Brien Shelly Chief Legal Officer
X 40,223
CROWELL GAYLE A Director
X 7,185
Crager William President
X 195,688
Grinis Scott D Chief Technology Officer
X 204,567
D'Arrigo Peter Chief Financial Officer
X 39,229
Majoros Matthew Principal Accounting Officer
X 12,418
Bergman Judson Chief Executive Officer, Director
X X 734,071
Mayer Joshua Chief Operating Officer
X 48,517
Thomas Brandon Chief Investment Officer
X 278,398
Smith Gregory A Director
X 12,931
Roame Charles Director
X 22,976
Johnson James Director
X 7,161
FOX JAMES L Director
X 10,744
CHAPIN ROSS K Director
X 43,756
Aguilar Luis A Director
X 7,075
Egan Cynthia Director
X
Sisteron Yves Director
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-04-02 4 CROWELL GAYLE A By trust S X I 57.10 -745 7,185 410,264
2018-04-02 4 O'Brien Shelly S X D 57.10 -366 40,223 2,296,733
2018-04-02 4 O'Brien Shelly M X D 9.00 366 40,589
2018-04-02 4 Arora Anil S X D 57.40 -4,443 101,794 5,842,976
2018-03-28 4 Arora Anil F D 57.35 -3,091 106,237
2018-03-28 4 Thomas Brandon F D 57.35 -495 278,398
2018-03-28 4 Mayer Joshua F D 57.35 -614 48,517
2018-03-28 4 Bergman Judson F D 57.35 -4,720 734,071
2018-03-28 4 Majoros Matthew F D 57.35 -302 12,418
2018-03-28 4 D'Arrigo Peter F D 57.35 -1,128 39,229
2018-03-28 4 Grinis Scott D F D 57.35 -773 204,567
2018-03-28 4 O'Brien Shelly F D 57.35 -489 40,223
2018-03-28 4 Crager William F D 57.35 -1,576 195,688
2018-03-22 4 Grinis Scott D S D 59.75 -40,000 205,340 12,269,065
2018-03-16 4 Mayer Joshua S D 57.88 -6,743 49,131 2,843,702
2018-03-07 4 Arora Anil F D 57.25 -2,882 109,328
2018-03-05 4 Arora Anil S X D 57.40 -557 112,210 6,440,854
2018-03-01 4 O'Brien Shelly S X D 54.91 -3,000 40,712 2,235,496
2018-03-01 4 O'Brien Shelly M X D 9.00 3,000 43,712
2018-03-01 4 Arora Anil S X D 54.80 -2,136 112,767 6,179,632
2018-03-01 4 CROWELL GAYLE A By trust S X I 54.85 -746 7,930 434,960
2018-02-28 4 Aguilar Luis A A D 2,276 7,075
2018-02-28 4 CHAPIN ROSS K A D 2,852 43,756
2018-02-28 4 CROWELL GAYLE A A D 2,386 8,676
2018-02-28 4 FOX JAMES L A D 2,580 10,744
2018-02-28 4 Johnson James A D 2,314 7,161
2018-02-28 4 Roame Charles A I 2,541 22,976
2018-02-28 4 Smith Gregory A A D 2,807 12,931
2018-02-28 4 Arora Anil A D -19,000 114,903
2018-02-28 4 Bergman Judson A D 38,000 738,791
2018-02-28 4 Bergman Judson F D 55.10 -1,352 700,791
2018-02-28 4 Crager William A D 20,000 197,264
2018-02-28 4 Crager William F D 55.10 -832 177,264
2018-02-28 4 D'Arrigo Peter A D 13,000 40,357
2018-02-28 4 D'Arrigo Peter F D 55.10 -642 27,357
2018-02-28 4 Grinis Scott D A D 7,000 245,340
2018-02-28 4 Grinis Scott D F D 55.10 -556 238,340
2018-02-28 4 Majoros Matthew A D 3,535 12,720
2018-02-28 4 Majoros Matthew F D 55.10 -250 9,185
2018-02-28 4 Mayer Joshua A D 7,000 55,874
2018-02-28 4 Mayer Joshua F D 55.10 -441 48,874
2018-02-28 4 O'Brien Shelly A D 5,500 40,712
2018-02-28 4 O'Brien Shelly F D 55.10 -374 35,212
2018-02-28 4 Thomas Brandon A D 6,000 278,893
2018-02-28 4 Thomas Brandon F D 55.10 -374 272,893
2018-02-27 4 Roame Charles P I 57.545 271 20,435 1,175,932
2018-02-15 4 Arora Anil S X D 54.80 -755 95,903 5,255,484
2018-02-02 4 Grinis Scott D F D 52.75 -1,136 239,896
2018-02-02 4 Mayer Joshua F D 52.75 -1,134 49,315
2018-02-02 4 O'Brien Shelly F D 52.75 -600 35,586
2018-02-02 4 Thomas Brandon F D 52.75 -577 273,267
2018-02-01 4 CROWELL GAYLE A By trust S X I 53.20 -746 6,290 334,628
2018-02-01 4 O'Brien Shelly S X D 53.06 -3,000 36,186 1,920,029
2018-02-01 4 O'Brien Shelly M X D 9.00 3,000 39,186
2018-01-30 4 Arora Anil S X D 54.80 -7,109 96,658 5,296,858
2018-01-11 4 Arora Anil S X D 54.18 -7,236 103,767 5,622,096
2018-01-11 4 Arora Anil S X D 53.10 -2,764 111,003 5,894,259
2018-01-02 4 O'Brien Shelly S X D 50.00 -3,000 36,186 1,809,300
2018-01-02 4 O'Brien Shelly M X D 9.00 3,000 39,186
2018-01-02 4 CROWELL GAYLE A By trust S X I 50.00 -746 7,036 351,800
2017-12-22 4 Mayer Joshua S D 52.04 -10,000 50,449 2,625,366
2017-12-22 4 Mayer Joshua M D 12.55 10,000 60,449
2017-12-22 4 Mayer Joshua S D 52.07 -20,000 50,449 2,626,879
2017-12-22 4 Mayer Joshua M D 9.00 20,000 70,449
2017-12-22 4 Mayer Joshua S D 52.20 -800 50,449 2,633,438
2017-12-22 4 Mayer Joshua M D 7.15 800 51,249
2017-12-15 4 D'Arrigo Peter S X D 49.87 -23,437 27,999 1,396,310
2017-12-15 4 D'Arrigo Peter M X D 7.50 23,437 51,436
2017-12-11 4 Mayer Joshua S D 49.75 -2,000 50,449 2,509,838
2017-12-11 4 D'Arrigo Peter S X D 49.73 -220 27,999 1,392,390
2017-12-11 4 D'Arrigo Peter M X D 7.50 220 28,219
2017-12-08 4 D'Arrigo Peter S X D 50.09 -29,780 27,999 1,402,470
2017-12-08 4 D'Arrigo Peter M X D 7.50 29,780 57,779
2017-12-07 4 Arora Anil F D 49.65 -4,349 113,767
2017-12-07 4 Arora Anil M D 8,333 118,116
2017-12-06 4 D'Arrigo Peter S X D 50.00 -10,000 27,999 1,399,950
2017-12-06 4 D'Arrigo Peter M X D 7.50 10,000 37,999
2017-12-06 4 O'Brien Shelly S X D 50.00 -1,500 36,186 1,809,300
2017-12-06 4 O'Brien Shelly M X D 9.00 1,500 37,686
2017-12-01 4 O'Brien Shelly S X D 48.47 -1,000 36,186 1,753,935
2017-12-01 4 O'Brien Shelly S X D 47.45 -500 37,186 1,764,476
2017-12-01 4 O'Brien Shelly M X D 9.00 1,500 37,686
2017-12-01 4 CROWELL GAYLE A By trust S X I 48.90 -746 7,782 380,540
2017-12-01 4 D'Arrigo Peter S X D 48.56 -3,500 27,999 1,359,631
2017-12-01 4 D'Arrigo Peter S X D 48.02 -16,500 31,499 1,512,582
2017-12-01 4 D'Arrigo Peter M X D 7.50 20,000 47,999
2017-11-29 4 Smith Gregory A M D 55 10,124
2017-11-29 4 Bergman Judson F D 48.40 -349 732,220
2017-11-29 4 Bergman Judson S X D 50.25 -400 732,569 36,811,592
2017-11-29 4 Bergman Judson S X D 48.64 -9,600 732,969 35,651,612
2017-11-29 4 Bergman Judson M X D 9 10,000 742,569
2017-11-29 4 Crager William F D 48.40 -221 178,096
2017-11-29 4 D'Arrigo Peter F D 48.40 -166 27,999
2017-11-29 4 Grinis Scott D F D 48.40 -141 241,032
2017-11-29 4 Majoros Matthew F D 48.40 -39 9,435
2017-11-29 4 Majoros Matthew M D 119 9,474
2017-11-29 4 Mayer Joshua F D 48.40 -83 52,449
2017-11-29 4 O'Brien Shelly F D 48.40 -97 36,186
2017-11-29 4 Thomas Brandon F D 48.40 -67 273,844
2017-11-29 4 CHAPIN ROSS K M D 64 40,904
2017-11-29 4 FOX JAMES L M D 55 8,164
2017-11-29 4 Johnson James M D 61 4,847
2017-11-28 4 D'Arrigo Peter S X D 50.00 -6,890 28,165 1,408,250
2017-11-28 4 D'Arrigo Peter M X D 7.50 6,890 35,055
2017-11-28 4 Bergman Judson S X D 49.55 -10,000 732,569 36,298,794
2017-11-28 4 Bergman Judson M X D 9 10,000 742,569
2017-11-27 4 D'Arrigo Peter S X D 50.01 -3,105 28,165 1,408,532
2017-11-27 4 D'Arrigo Peter M X D 7.50 3,105 31,270
2017-11-27 4 Bergman Judson S X D 49.77 -10,000 732,569 36,459,959
2017-11-27 4 Bergman Judson M X D 9 10,000 742,569
2017-11-24 4 D'Arrigo Peter S X D 49.68 -20,005 28,165 1,399,237
2017-11-24 4 D'Arrigo Peter M X D 7.50 20,005 48,170
2017-11-22 4 Bergman Judson S X D 49.39 -10,000 732,569 36,181,583
2017-11-22 4 Bergman Judson M X D 9 10,000 742,569
2017-11-21 4 Bergman Judson S X D 49.91 -10,000 732,569 36,562,519
2017-11-21 4 Bergman Judson M X D 9.00 10,000 742,569
2017-11-20 4 Bergman Judson S X D 49.55 -10,000 732,569 36,298,794
2017-11-20 4 Bergman Judson M X D 9.00 9,000 742,569
2017-11-20 4 Bergman Judson M X D 7.15 1,000 733,569
2017-11-17 4 D'Arrigo Peter S X D 50.98 -1,700 28,165 1,435,852
2017-11-17 4 D'Arrigo Peter S X D 50.10 -28,300 29,865 1,496,236
2017-11-17 4 D'Arrigo Peter M X D 7.50 30,000 58,165
2017-11-13 4 Roame Charles P I 51.43 323 20,164 1,037,035
2017-11-10 4 Crager William S X D 51.48 -4,000 178,317 9,179,759
2017-11-10 4 Crager William M X D 7.50 4,000 182,317
2017-11-13 4 Bergman Judson S X D 51.48 -20,000 732,569 37,712,652
2017-11-13 4 Bergman Judson M X D 7.15 14,000 752,569
2017-11-13 4 Bergman Judson M X D 7.50 6,000 738,569
2017-11-10 4 D'Arrigo Peter S X D 52.45 -2,400 28,165 1,477,254
2017-11-10 4 D'Arrigo Peter S X D 51.41 -27,600 30,565 1,571,347
2017-11-10 4 D'Arrigo Peter M X D 7.50 30,000 58,165
2017-11-06 4 Bergman Judson S X D 53.21 -20,000 712,569 37,915,796
2017-11-03 4 Crager William S X D 52.75 -5,000 168,317 8,878,722
2017-11-02 4 Grinis Scott D F D 53.70 -1,523 241,173
2017-11-02 4 Grinis Scott D M D 2,917 242,696
2017-11-02 4 Mayer Joshua F D 53.70 -1,144 52,532
2017-11-02 4 Mayer Joshua M D 3,750 53,676
2017-11-02 4 Thomas Brandon F D 53.70 -539 273,911
2017-11-02 4 Thomas Brandon M D 1,667 274,450
2017-11-01 4 CROWELL GAYLE A By trust S X I 53.60 -746 5,331 285,742
2017-11-02 4 O'Brien Shelly F D 53.70 -977 30,283
2017-11-02 4 O'Brien Shelly M D 2,083 31,260
2017-11-01 4 O'Brien Shelly S X D 53.28 -3,000 7,292 388,518
2017-10-27 4 O'Brien Shelly S X D 53.48 -3,000 10,292 550,416
2017-10-27 4 Crager William S X D 53.31 -5,000 150,655 8,031,418
2017-10-02 4 CROWELL GAYLE A By trust S X I 51.20 -746 6,077 311,142
2017-09-28 4 Grinis Scott D S D 50.04 -9,308 209,708 10,493,788
2017-09-27 4 O'Brien Shelly S D 49.96 -2,000 13,292 664,068
2017-09-27 4 O'Brien Shelly M D 7.15 2,000 15,292
2017-09-22 4 Arora Anil S X D 50.00 -16,418 56,447 2,822,350
2017-09-07 4 Arora Anil F D 42.85 -4,349 72,865
2017-09-07 4 Arora Anil M D 8,333 77,214
2017-09-01 4 CROWELL GAYLE A By trust S X I 44.45 -746 6,823 303,282
2017-08-30 4 Majoros Matthew S D 42.699 -500 4,936 210,762
2017-08-30 4 Majoros Matthew M D 13.45 500 5,436
2017-08-29 4 CHAPIN ROSS K M D 64 37,822
2017-08-29 4 O'Brien Shelly F D 42.650 -97 13,292
2017-08-29 4 O'Brien Shelly M D 205 13,389
2017-08-29 4 Roame Charles M D 53 15,848
2017-08-29 4 Thomas Brandon F D 42.650 -67 253,745
2017-08-29 4 Thomas Brandon M D 205 253,812
2017-08-29 4 Johnson James M D 60 2,136
2017-08-29 4 Bergman Judson F D 42.650 -349 689,681
2017-08-29 4 Bergman Judson M D 744 690,030
2017-08-29 4 Smith Gregory A M D 55 5,744
2017-08-29 4 D'Arrigo Peter F D 42.650 -166 12,663
2017-08-29 4 D'Arrigo Peter M D 353 12,829
2017-08-29 4 Crager William F D 42.650 -220 155,655
2017-08-29 4 Crager William M D 487 155,875
2017-08-29 4 Grinis Scott D F D 42.650 -141 219,016
2017-08-29 4 Grinis Scott D M D 269 219,157
2017-08-29 4 Mayer Joshua F D 42.650 -83 14,024
2017-08-29 4 Mayer Joshua M D 269 14,107
2017-08-29 4 Majoros Matthew F D 42.650 -39 4,936
2017-08-29 4 Majoros Matthew M D 119 4,975
2017-08-29 4 FOX JAMES L M D 55 3,744
2017-08-18 4 Mayer Joshua S D 43.663 -1,500 13,838 604,209
2017-08-11 4 Roame Charles P I 43.0569 238 15,795 680,084
2017-08-02 4 O'Brien Shelly F D -952 13,184
2017-08-02 4 O'Brien Shelly M D 2,083 14,136
2017-08-02 4 Thomas Brandon F D -519 253,607
2017-08-02 4 Thomas Brandon M D 1,666 254,126
2017-08-02 4 Grinis Scott D F D -1,522 218,848
2017-08-02 4 Grinis Scott D M D 2,916 220,370
2017-08-02 4 Mayer Joshua F D -1,144 15,338
2017-08-02 4 Mayer Joshua M D 3,750 16,482
2017-08-01 4 CROWELL GAYLE A By trust S X I 39.20 -746 7,569 296,705
2017-07-24 4 Arora Anil S X D 40.00 -8,980 68,881 2,755,240
2017-07-03 4 CROWELL GAYLE A By trust S I 39.80 -746 8,315 330,937
2017-06-28 4 D'Arrigo Peter S D 39.20 -7,500 12,476 489,059
2017-06-28 4 D'Arrigo Peter M D 7.50 7,500 19,976
2017-06-28 4 Grinis Scott D S D 39.33 -6,000 217,454 8,552,466
2017-06-28 4 Grinis Scott D M D 7.15 6,000 223,454
2017-06-28 4 Grinis Scott D S D 39.41 -3,410 217,454 8,569,862
2017-06-28 4 Grinis Scott D S D 38.97 -5,590 220,864 8,607,070
2017-06-28 4 Grinis Scott D M D 7.50 9,000 226,454
2017-06-07 4 Arora Anil F D 36.25 -3,264 77,861
2017-06-07 4 Arora Anil M D 8,333 81,125
2017-06-02 4 CROWELL GAYLE A By trust P I 37.50 2,238 12,736 477,600
2017-05-31 4 Roame Charles By Tiburon Strategic Advisors, LLC P I 35.3829 19 4,894 173,164
2017-05-31 4 Roame Charles P I 35.375 1,454 12,392 438,367
2017-05-29 4 CHAPIN ROSS K M D 64 37,758
2017-05-29 4 FOX JAMES L M D 55 3,689
2017-05-29 4 Johnson James M D 60 2,076
2017-05-29 4 Roame Charles M D 53 14,031
2017-05-29 4 Smith Gregory A M D 55 5,689
2017-05-29 4 Bergman Judson F D -341 689,286
2017-05-29 4 Bergman Judson M D 744 689,627
2017-05-29 4 Crager William F D -220 155,388
2017-05-29 4 Crager William M D 487 155,608
2017-05-29 4 D'Arrigo Peter F D -110 12,476
2017-05-29 4 D'Arrigo Peter M D 353 12,586
2017-05-29 4 Grinis Scott D F D -102 217,454
2017-05-29 4 Grinis Scott D M D 269 217,556
2017-05-29 4 O'Brien Shelly F D -94 12,053
2017-05-29 4 O'Brien Shelly M D 205 12,147
2017-05-29 4 Majoros Matthew F D -37 4,856
2017-05-29 4 Majoros Matthew M D 119 4,893
2017-05-29 4 Mayer Joshua F D -83 12,732
2017-05-29 4 Mayer Joshua M D 269 12,815
2017-05-29 4 Thomas Brandon F D -64 252,460
2017-05-29 4 Thomas Brandon M D 205 252,524
2017-05-15 4 Roame Charles G I -257 12,355
2017-05-15 4 Roame Charles P D 35.98 257 3,403 122,440
2017-05-12 4 Crager William F D -7,515 155,121
2017-05-12 4 Crager William M D 16,666 162,636
2017-05-12 4 Bergman Judson F D -19,042 688,883
2017-05-12 4 Bergman Judson M D 41,666 707,925
2017-05-12 4 D'Arrigo Peter F D -3,110 12,233
2017-05-12 4 D'Arrigo Peter M D 10,000 15,343
2017-05-02 4 Thomas Brandon F D -519 252,319
2017-05-02 4 Thomas Brandon M D 1,666 252,838
2017-05-02 4 Mayer Joshua F D -1,144 12,546
2017-05-02 4 Mayer Joshua M D 3,750 13,690
2017-05-02 4 O'Brien Shelly F D -892 11,942
2017-05-02 4 O'Brien Shelly M D 2,083 12,834
2017-05-01 4 O'Brien Shelly S D 34.85 -2,000 10,751 374,672
2017-05-01 4 O'Brien Shelly M D 7.50 2,000 12,751
2017-05-02 4 Grinis Scott D F D -1,096 217,287
2017-05-02 4 Grinis Scott D M D 2,916 218,383
2017-04-26 4 Aguilar Luis A M D 801 1,602
2017-04-26 4 CROWELL GAYLE A M D 801 11,299
2017-04-25 4 O'Brien Shelly S D 35.00 -1,000 10,751 376,285
2017-04-25 4 O'Brien Shelly M D 7.50 1,000 11,751
2017-04-03 4 O'Brien Shelly S D 32.26 -2,000 10,751 346,827
2017-04-03 4 O'Brien Shelly M D 7.50 2,000 12,751
2017-04-03 4 O'Brien Shelly S D 32.33 -7,403 10,751 347,580
2017-04-03 4 O'Brien Shelly M D 7.50 7,403 18,154
2017-04-03 4 Crager William By wife S I 32.32 -2,352 145,970 4,717,750
2017-04-03 4 Crager William M D 7.50 2,352 148,322
2017-03-31 4 Bergman Judson P D 32.40 1,000 666,259 21,586,792
2017-03-31 4 Bergman Judson M D 7.50 10,000 665,259
2017-03-28 4 Roame Charles G I -276 12,098
2017-03-28 4 Roame Charles P D 31.25 276 3,422 106,938
2017-03-27 4 Crager William S D 31.33 -2,500 145,970 4,573,240
2017-03-27 4 Crager William M D 7.50 2,500 148,470
2017-03-20 4 Crager William S D 35.13 -512 145,970 5,127,926
2017-03-20 4 Crager William M D 7.50 512 146,482
2017-03-20 4 Crager William S D 34.52 -1,988 145,970 5,038,884
2017-03-20 4 Crager William M D 7.50 1,988 147,958
2017-03-13 4 Crager William S D 35.16 -1,417 145,970 5,132,305
2017-03-13 4 Crager William M D 7.50 1,417 147,387
2017-03-13 4 Crager William S D 34.96 -1,083 145,970 5,103,111
2017-03-13 4 Crager William M D 7.50 1,083 147,053
2017-03-07 4 Arora Anil F D -3,132 73,892
2017-03-07 4 Arora Anil M D 8,333 77,024
2017-03-06 4 Crager William S D 36.65 -2,500 145,970 5,349,800
2017-03-06 4 Crager William M D 7.50 2,500 148,470
2017-03-03 4 Arora Anil S D 37.50 -1,100 67,591 2,534,662
2017-02-28 4 Roame Charles M D 213 13,498
2017-02-28 4 Roame Charles M D 1,463 13,285
2017-02-28 4 Smith Gregory A M D 221 5,634
2017-02-28 4 Smith Gregory A M D 1,463 5,413
2017-03-01 4 CROWELL GAYLE A By trust S I 39.00 -746 10,498 409,422
2017-02-28 4 FOX JAMES L M D 221 3,634
2017-02-28 4 FOX JAMES L M D 1,463 3,413
2017-02-28 4 Johnson James M D 242 2,016
2017-02-28 4 Thomas Brandon F D -256 251,172
2017-02-28 4 Thomas Brandon M D 821 251,428
2017-02-28 4 Thomas Brandon F D -332 250,607
2017-02-28 4 Thomas Brandon M D 1,067 250,939
2017-02-28 4 Thomas Brandon F D -415 249,872
2017-02-28 4 Thomas Brandon M D 1,334 250,287
2017-03-02 4 Arora Anil S D 38.40 -400 68,691 2,637,734
2017-03-02 4 Arora Anil S D 37.27 -2,869 69,091 2,575,022
2017-03-02 4 Arora Anil S D 36.79 -1,031 71,960 2,647,408
2017-02-28 4 CHAPIN ROSS K M D 256 37,694
2017-02-28 4 Mayer Joshua F D -329 9,940
2017-02-28 4 Mayer Joshua M D 1,078 10,269
2017-02-28 4 Mayer Joshua F D -407 93
2017-02-28 4 Mayer Joshua F D -407 93
2017-02-28 4 Mayer Joshua M D 1,333 9,598
2017-02-28 4 Mayer Joshua M D 1,334 8,672
2017-03-01 4 O'Brien Shelly S D 39.00 -1,500 10,751 419,289
2017-03-01 4 O'Brien Shelly M D 7.50 1,500 12,251
2017-03-01 4 O'Brien Shelly S D 38.95 -3,000 10,751 418,751
2017-03-01 4 O'Brien Shelly M D 7.50 3,000 13,751
2017-02-28 4 O'Brien Shelly F D -256 10,751
2017-02-28 4 O'Brien Shelly M D 821 11,007
2017-02-28 4 O'Brien Shelly F D -332 10,186
2017-02-28 4 O'Brien Shelly M D 1,067 10,518
2017-02-28 4 O'Brien Shelly F D -374 9,451
2017-02-28 4 O'Brien Shelly M D 1,200 9,825
2017-02-28 4 Grinis Scott D F D -406 215,467
2017-02-28 4 Grinis Scott D M D 1,078 215,873
2017-02-28 4 Grinis Scott D F D -501 214,795
2017-02-28 4 Grinis Scott D M D 1,333 215,296
2017-02-28 4 Grinis Scott D F D -502 213,963
2017-02-28 4 Grinis Scott D M D 1,334 214,465
2017-02-28 4 Majoros Matthew F D -148 4,774
2017-02-28 4 Majoros Matthew M D 476 4,922
2017-02-28 4 Majoros Matthew F D -221 4,446
2017-02-28 4 Majoros Matthew M D 608 4,667
2017-02-28 4 Majoros Matthew F D -249 4,059
2017-02-28 4 Majoros Matthew M D 667 4,308
2017-02-28 4 Bergman Judson F D -926 655,259
2017-02-28 4 Bergman Judson M D 2,977 656,185
2017-02-28 4 Bergman Judson F D -1,203 653,208
2017-02-28 4 Bergman Judson M D 3,867 654,411
2017-02-28 4 Bergman Judson F D -1,307 650,544
2017-02-28 4 Bergman Judson M D 4,200 651,851
2017-02-28 4 Crager William F D -880 145,970
2017-02-28 4 Crager William M D 1,950 146,850
2017-02-28 4 Crager William F D -1,124 144,900
2017-02-28 4 Crager William M D 2,533 146,024
2017-02-28 4 Crager William F D -905 143,491
2017-02-28 4 Crager William M D 2,967 144,396
2017-02-28 4 D'Arrigo Peter F D -439 5,343
2017-02-28 4 D'Arrigo Peter M D 1,411 5,782
2017-02-28 4 D'Arrigo Peter F D -571 4,371
2017-02-28 4 D'Arrigo Peter M D 1,833 4,942
2017-02-28 4 D'Arrigo Peter F D -685 3,109
2017-02-28 4 D'Arrigo Peter M D 2,200 3,794
2017-02-27 4 Crager William S D 38.67 -2,500 141,429 5,469,059
2017-02-27 4 Crager William M D 7.50 2,500 143,929
2017-02-21 4 Crager William S D 38.26 -2,200 141,429 5,411,074
2017-02-21 4 Crager William M D 7.50 2,200 143,629
2017-02-21 4 Crager William S D 37.90 -300 141,429 5,360,159
2017-02-21 4 Crager William M D 7.50 300 141,729
2017-02-13 4 Crager William S D 38.17 -1,301 141,429 5,398,345
2017-02-13 4 Crager William M D 7.50 1,301 142,730
2017-02-13 4 Crager William S D 37.73 -1,199 141,429 5,336,116
2017-02-13 4 Crager William M D 7.50 1,199 142,628
2017-02-06 4 Crager William S D 38.04 -700 141,429 5,379,959
2017-02-06 4 Crager William M D 7.50 700 142,129
2017-02-06 4 Crager William S D 37.90 -1,800 141,429 5,360,159
2017-02-06 4 Crager William M D 7.50 1,800 143,229
2017-02-01 4 CROWELL GAYLE A By trust S I 37.80 -746 11,244 425,023
2017-02-01 4 O'Brien Shelly S D 37.95 -4,500 5,740 217,833
2017-02-01 4 O'Brien Shelly M D 7.50 4,500 10,240
2017-01-30 4 Crager William S D 3702 -507 141,429 523,570,158
2017-01-30 4 Crager William M D 7.50 507 143,936
2017-01-30 4 Crager William S D 36.87 -1,993 141,429 5,214,487
2017-01-30 4 Crager William M D 7.50 1,993 143,422
2017-01-25 4 Arora Anil S D 37.50 -8,208 72,991 2,737,162
2017-01-23 4 Crager William S D 36.72 -2,500 141,429 5,193,273
2017-01-23 4 Crager William M D 7.50 2,500 143,929
2017-01-18 4 Arora Anil S D 37.05 -3,356 87,823 3,253,842
2017-01-18 4 Arora Anil S D 36.70 -75 91,179 3,346,269
2017-01-17 4 Crager William S D 37.50 -58 141,429 5,303,588
2017-01-17 4 Crager William M D 7.50 58 141,487
2017-01-17 4 Crager William S D 36.58 -2,442 141,429 5,173,473
2017-01-17 4 Crager William M D 7.50 2,442 143,871
2017-01-13 4 CROWELL GAYLE A By trust S I 37.50 -746 11,990 449,625
2017-01-09 4 Crager William S D 36.72 -2,500 141,429 5,193,273
2017-01-09 4 Crager William M D 7.50 2,500 143,929
2017-01-03 4 O'Brien Shelly S D 35.45 -4,500 5,740 203,483
2017-01-03 4 O'Brien Shelly M D 7.50 4,500 10,240
2017-01-03 4 Crager William S D 36.15 -65 141,429 5,112,658
2017-01-03 4 Crager William M D 7.50 65 141,494
2017-01-03 4 Crager William S D 35.30 -700 141,429 4,992,444
2017-01-03 4 Crager William M D 7.50 700 142,129
2017-01-03 4 Crager William S D 34.83 -1,735 141,429 4,925,972
2017-01-03 4 Crager William M D 7.50 1,735 143,164
2016-12-29 4 Mayer Joshua S D 35.60 -2,439 2,280 81,168
2016-12-27 4 Crager William S D 35.33 -2,500 141,429 4,996,687
2016-12-27 4 Crager William M D 7.50 2,500 143,929
2016-12-19 4 Crager William S D 36.30 -2,500 141,429 5,133,873
2016-12-19 4 Crager William M D 7.50 2,500 143,929
2016-12-15 4 CROWELL GAYLE A By trust S I 37.50 -746 12,736 477,600
2016-12-15 4 Arora Anil S D 37.50 -840 91,254 3,422,025
2016-12-07 4 Arora Anil F D -4,349 92,094
2016-12-07 4 Arora Anil M D 8,333 96,443
2016-12-05 4 Arora Anil S D 35.00 -840 88,110 3,083,850
2016-12-01 4 O'Brien Shelly S D 35.86 -4,500 5,740 205,836
2016-12-01 4 O'Brien Shelly M D 7.50 4,500 10,240
2016-11-21 4 Bergman Judson S D 38.20 -9,000 658,106 25,139,649
2016-11-21 4 Bergman Judson M D 7.50 9,000 669,106
2016-11-21 4 Bergman Judson S D 37.92 -1,000 649,106 24,614,100
2016-11-21 4 Bergman Judson M D 7.50 1,000 650,106
2016-11-17 4 CROWELL GAYLE A By trust S I 37.50 -746 13,482 505,575
2016-11-14 4 Bergman Judson S D 35.68 -20,000 649,106 23,160,102
2016-11-14 4 Bergman Judson M D 7.50 20,000 669,106
2016-11-11 4 Bergman Judson S D 35 -7,031 649,106 22,718,710
2016-11-11 4 Bergman Judson M D 7.50 7,031 656,137
2016-11-10 4 Roame Charles G I -250 11,822
2016-11-10 4 Roame Charles P D 33.65 250 3,396 114,275
2016-11-08 4 Bergman Judson S D 35.00 -1,069 649,106 22,718,710
2016-11-08 4 Bergman Judson M D 7.50 1,069 650,175
2016-11-07 4 Bergman Judson S D 35.00 -3,800 649,106 22,718,710
2016-11-07 4 Bergman Judson M D 7.50 3,800 652,906
2016-11-07 4 Bergman Judson S D 34.58 -8,100 649,106 22,446,085
2016-11-07 4 Bergman Judson M D 7.50 8,100 657,206
2016-11-04 4 Crager William S D 34.35 -2,854 141,429 4,858,086
2016-11-04 4 Crager William M D 7.5 2,854 144,283
2016-11-04 4 Crager William S D 33.95 -100 141,429 4,801,515
2016-11-04 4 Crager William M D 7.50 100 141,529
2016-11-03 4 Crager William S D 33.76 -10,000 141,429 4,774,643
2016-11-03 4 Crager William M D 7.50 10,000 161,429
2016-11-01 4 O'Brien Shelly S D 35.15 -4,500 5,740 201,761
2016-11-01 4 O'Brien Shelly M D 7.50 4,500 10,240
2016-11-02 4 Crager William S D 34.79 -10,000 141,429 4,920,315
2016-11-02 4 Crager William M D 7.50 10,000 151,429
2016-11-01 4 Crager William S D 35.24 -17,194 141,429 4,983,958
2016-11-01 4 Crager William M D 7.50 17,194 161,429
2016-11-01 4 Crager William S D 35.24 -2,806 141,429 4,983,958
2016-11-01 4 Crager William M D 1.075 2,806 144,235
2016-10-31 4 Crager William S D 34.96 -17,194 141,429 4,944,358
2016-10-31 4 Crager William M D 1.075 17,194 161,429
2016-10-31 4 Crager William S D 35.00 -2,806 141,429 4,950,015
2016-10-31 4 Crager William M D 0.1069 2,806 144,235
2016-10-31 4 Bergman Judson S D 35.00 -10,000 649,106 22,718,710
2016-10-31 4 Bergman Judson M D 7.50 10,000 659,106
2016-10-31 4 Bergman Judson M D 7.50 10,000 659,106
2016-10-31 4 Bergman Judson S D 34.88 -10,000 649,106 22,640,817
2016-10-24 4 Bergman Judson S D 37.31 -20,000 649,106 24,218,145
2016-10-24 4 Bergman Judson M D 7.50 20,000 669,106
2016-10-17 4 Bergman Judson S D 35.52 -20,000 649,106 23,056,245
2016-10-17 4 Bergman Judson M D 7.50 20,000 669,106
2016-10-10 4 Bergman Judson S D 37.00 -12 649,106 24,016,922
2016-10-10 4 Bergman Judson M D 7.50 12,471 661,577
2016-10-10 4 Bergman Judson S D 36.95 -7,529 649,106 23,984,467
2016-10-10 4 Bergman Judson M D 7.50 7,529 656,635
2016-10-03 4 O'Brien Shelly S D 36.25 -4,500 5,740 208,075
2016-10-03 4 O'Brien Shelly M D 7.50 4,500 10,240
2016-10-03 4 Bergman Judson S D 36.28 -20,000 649,106 23,549,566
2016-10-03 4 Bergman Judson M D 7.50 20,000 669,106
2016-09-23 4 Grinis Scott D S D 39.16 -12,000 210,668 8,249,759
2016-09-23 4 Grinis Scott D M D 7.50 12,000 222,668
2016-09-26 4 Bergman Judson S D 38.33 -20,000 649,106 24,880,233
2016-09-26 4 Bergman Judson M D 7.50 20,000 669,106
2016-09-07 4 Arora Anil F D -4,349 88,950
2016-09-07 4 Arora Anil M D 8,333 93,299
2016-09-02 4 Arora Anil S D 40.33 -2,520 84,966 3,426,679
2016-09-02 4 O'Brien Shelly S D 40.01 -1,000 5,740 229,657
2016-09-02 4 O'Brien Shelly M D 7.50 1,000 6,740
2016-09-01 4 O'Brien Shelly S D 39.66 -4,500 5,740 227,648
2016-09-01 4 O'Brien Shelly M D 7.50 4,500 10,240
2016-08-11 4 Roame Charles G I -238 11,572
2016-08-11 4 Roame Charles P D 37.58 238 3,384 127,171
2016-08-04 4 O'Brien Shelly S D 40.00 -1,000 5,740 229,600
2016-08-04 4 O'Brien Shelly M D 7.50 1,000 6,740
2016-08-03 4 Arora Anil S D 40.00 -4,900 87,486 3,499,440
2016-08-01 4 O'Brien Shelly S D 37.99 -2,400 5,740 218,063
2016-08-01 4 O'Brien Shelly M D 7.5 2,400 8,140
2016-08-01 4 O'Brien Shelly S D 38.01 -2,100 5,740 218,177
2016-08-01 4 O'Brien Shelly M D 7.5 2,100 7,840
2016-07-30 4 Roame Charles J I -164 11,334
2016-07-30 4 Roame Charles M D 164 3,310
2016-07-26 4 Arora Anil S D 37.50 -1,750 92,386 3,464,475
2016-07-08 4 O'Brien Shelly S D 35.00 -1,000 5,740 200,900
2016-07-08 4 O'Brien Shelly M D 7.5 1,000 6,740
2016-07-01 4 O'Brien Shelly S D 33.64 -3,500 5,740 193,094
2016-07-01 4 O'Brien Shelly M D 7.5 3,500 9,240
2016-06-17 4 D'Arrigo Peter S D 35.69 -6,294 1,594 56,890
2016-06-17 4 D'Arrigo Peter S D 35.66 -6,000 7,888 281,286
2016-06-17 4 D'Arrigo Peter M D 7.5 6,000 13,888
2016-06-07 4 Arora Anil F D -4,046 94,136
2016-06-07 4 Arora Anil M D 8,333 98,182
2016-06-06 4 Arora Anil S D 37.50 -3,150 89,849 3,369,338
2016-06-02 4 Arora Anil S D 35.00 -3,500 93,010 3,255,350
2016-06-02 4 Arora Anil S D 35.61 -1,750 96,510 3,436,721
2016-06-02 4 O'Brien Shelly S D 35.00 -1,000 5,740 200,900
2016-06-02 4 O'Brien Shelly M D 7.5 1,000 6,740
2016-06-01 4 O'Brien Shelly S D 33.73 -3,500 5,740 193,610
2016-06-01 4 O'Brien Shelly M D 7.5 3,500 9,240
2016-05-31 4 O'Brien Shelly S D 33.66 -3,500 5,740 193,208
2016-05-31 4 O'Brien Shelly M D 7.5 3,500 9,240
2016-05-10 4 Roame Charles P D 31.65 282 11,452 362,456
2016-05-10 4 Roame Charles G I -282 11,452
2016-05-10 4 Roame Charles By Tiburon Strategic Advisors, LLC P I 31.74 3,146 11,452 363,486
2016-04-26 4 CROWELL GAYLE A M D 801 14,228
2016-04-26 4 Aguilar Luis A M D 801 801
2016-03-07 4 Arora Anil M D 8,333 431,366
2016-03-07 4 Arora Anil F D -4,046 431,366
2016-01-29 4 Arora Anil M D 100,809 431,366
2016-01-29 4 Arora Anil F D -43,670 431,366
2016-02-29 4 FOX JAMES L M D 1,950 1,950
2016-02-29 4 Smith Gregory A M D 1,950 5,950
2016-02-28 4 Thomas Brandon M D 3,439 480,608
2016-02-28 4 Thomas Brandon F D -1,050 480,608
2016-03-02 4 Roame Charles P D 20.04 75 25,101 503,024
2016-03-02 4 Roame Charles G I -75 25,101
2016-03-01 4 Roame Charles P D 20.73 325 25,101 520,344
2016-03-01 4 Roame Charles G I -325 25,101
2016-02-29 4 Roame Charles M D 1,950 25,101
2016-02-29 4 Roame Charles G I -1,950 25,101
2016-02-29 4 Egan Cynthia M D 1,950 1,950
2016-02-28 4 O'Brien Shelly M D 3,199 12,465
2016-02-28 4 O'Brien Shelly F D -983 12,465
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...